BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 24647726)

  • 1. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
    Bowen S; Witkiewitz K; Clifasefi SL; Grow J; Chawla N; Hsu SH; Carroll HA; Harrop E; Collins SE; Lustyk MK; Larimer ME
    JAMA Psychiatry; 2014 May; 71(5):547-56. PubMed ID: 24647726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race/ethnicity and racial group composition moderate the effectiveness of mindfulness-based relapse prevention for substance use disorder.
    Greenfield BL; Roos C; Hagler KJ; Stein E; Bowen S; Witkiewitz KA
    Addict Behav; 2018 Jun; 81():96-103. PubMed ID: 29454179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.
    Witkiewitz K; Bowen S
    J Consult Clin Psychol; 2010 Jun; 78(3):362-374. PubMed ID: 20515211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial.
    Skrzynski CJ; Karoly H; Ellingson JM; Hagerty SL; Bryan AD; Hutchison KE
    J Stud Alcohol Drugs; 2023 Jul; 84(4):560-569. PubMed ID: 36971735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of mindfulness-based relapse prevention in a sample of veterans in a substance use disorder aftercare program: A randomized controlled trial.
    Killeen TK; Baker NL; Davis LL; Bowen S; Brady KT
    J Subst Use Addict Treat; 2023 Sep; 152():209116. PubMed ID: 37364669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: Results from a randomized trial.
    Davis JP; Berry D; Dumas TM; Ritter E; Smith DC; Menard C; Roberts BW
    J Subst Abuse Treat; 2018 Aug; 91():37-48. PubMed ID: 29910013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial.
    Schneegans A; Bourgognon F; Albuisson E; Schwan R; Arfa M; Polli L; Moulard M; Laprévote V; Schwitzer T
    Encephale; 2022 Jun; 48(3):241-246. PubMed ID: 34092381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial.
    Zgierska AE; Burzinski CA; Mundt MP; McClintock AS; Cox J; Coe CL; Miller MM; Fleming MF
    J Subst Abuse Treat; 2019 May; 100():8-17. PubMed ID: 30898331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enactment of home practice following mindfulness-based relapse prevention and its association with substance-use outcomes.
    Grow JC; Collins SE; Harrop EN; Marlatt GA
    Addict Behav; 2015 Jan; 40():16-20. PubMed ID: 25218066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness practice moderates the relationship between craving and substance use in a clinical sample.
    Enkema MC; Bowen S
    Drug Alcohol Depend; 2017 Oct; 179():1-7. PubMed ID: 28734167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a randomized controlled trial of mindfulness-based relapse prevention for opioid use disorders.
    Zinzow H; Shi L; Rennert L; Chen L; Lopes S; Zhang L; Jones K; Jindal M; Stam C; Mclain M
    Contemp Clin Trials; 2020 Dec; 99():106182. PubMed ID: 33080378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating substance use treatment efficacy for younger and older adults.
    Dingle T; Bowen S
    Addict Behav; 2021 Jan; 112():106618. PubMed ID: 32889444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
    Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
    Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Mindfulness-Based Relapse Prevention Program as an Adjunct to the Standard Treatment for Smoking: A Pragmatic Design Pilot Study.
    Weiss de Souza IC; Kozasa EH; Bowen S; Richter KP; Sartes LMA; Colugnati FAB; Noto AR
    Nicotine Tob Res; 2020 Aug; 22(9):1605-1613. PubMed ID: 32222767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual gender and group gender composition as predictors of differential benefit from mindfulness-based relapse prevention for substance use disorders.
    Roos C; Stein E; Bowen S; Witkiewitz K
    Mindfulness (N Y); 2019 Aug; 10(8):1560-1567. PubMed ID: 31741686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindfulness-Based Relapse Prevention and Transcranial Direct Current Stimulation to Reduce Heavy Drinking: A Double-Blind Sham-Controlled Randomized Trial.
    Witkiewitz K; Stein ER; Votaw VR; Wilson AD; Roos CR; Gallegos SJ; Clark VP; Claus ED
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1296-1307. PubMed ID: 30977904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, acceptability and preliminary outcomes of a mindfulness-based relapse prevention program in a naturalistic setting among treatment-seeking patients with alcohol use disorder: a prospective observational study.
    von Hammerstein C; Khazaal Y; Dupuis M; Aubin HJ; Benyamina A; Luquiens A; Romo L
    BMJ Open; 2019 Jun; 9(5):e026839. PubMed ID: 31154307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mindfulness-based relapse prevention in veterans with substance use disorders: Design and methodology of a randomized clinical trial.
    Brady KT; Killeen T; Baker NL
    Contemp Clin Trials; 2021 Jun; 105():106393. PubMed ID: 33857680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach coping and substance use outcomes following mindfulness-based relapse prevention among individuals with negative affect symptomatology.
    Roos C; Bowen S; Witkiewitz K
    Mindfulness (N Y); 2020 Oct; 11(10):2397-2410. PubMed ID: 33510820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining psychometric properties of distress tolerance and its moderation of mindfulness-based relapse prevention effects on alcohol and other drug use outcomes.
    Hsu SH; Collins SE; Marlatt GA
    Addict Behav; 2013 Mar; 38(3):1852-8. PubMed ID: 23266526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.